Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds Bookmark CommentsGo to comments Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who dont use the medications, researchers said Monday
Early observational data support this possibility, with some patients reporting fewer nodules and less drainage over time
Can lifestyle adjustments support better balance
approved Wegovy (semaglutide) by Novo Nordisk A/S, making it available to thousands of people with obesity in England
206,487 These changes lead to a reduction in the production of non-esterified fatty acids (LCFAs) and glucose, as well as a decrease in the synthesis of VLDL (Very Low-Density Lipoprotein)
If you experience any of the symptoms outlined in the checklist below, stop your medication and contact your healthcare provider or seek immediate medical attention
